Moreover, PrognoScan analysis revealed a correlation between higher PABPN1 expression and worse survival outcomes in many cancer types, including blood cancer (B-cell lymphoma), lung cancer, breast cancer, bladder cancer, esophagus cancer, brain cancer and colorectal cancer. This evidence concerns the gene PABPN1 and brain cancer.